Wellstar Kennestone Hospital is a major hospital located in Marietta, Georgia, serving most of northern and central Cobb County, Georgia. Kennestone Hospital opened in June 1950 as a 105-bed-facility. It was named after Kennesaw Mountain and Stone Mountain.

There are 633 beds in Wellstar Kennestone Hospital.

During the past decade, Wellstar Kennestone Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 41 clinical trials were completed, i.e. on average, 120.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 16 clinical trials were completed. i.e. 94.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wellstar Kennestone Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "Abbott Medical Devices" with 6 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "Abiomed Inc." with 3 trials sponsored and "Stryker Neurovascular" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellstar Kennestone Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Wellstar Kennestone Hospital" are "Coronary Artery Disease" (8 trials), "Ischemic Stroke" (5 trials), "Recurrent Breast Carcinoma" (4 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (4 trials). Many other conditions were trialed in "Wellstar Kennestone Hospital" in a lesser frequency.

Most popular intervention types in "Wellstar Kennestone Hospital" are "Drug" (42 trials), "Other" (31 trials), "Device" (30 trials), "Biological" (20 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (11 trials), "Bevacizumab" (10 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Wellstar Kennestone Hospital" are 64 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Wellstar Kennestone Hospital". undefined are not yet recruiting, 10 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Wellstar Kennestone Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Wellstar Kennestone Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 23 trials that are defined as “Not Applicable".

Wellstar Kennestone Hospital has several departments that took part in Clinical trials: "Kennestone Cancer Center at Wellstar Kennestone Hospital" - 61 trials, "Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital" - 16 trials, "Marietta Pulmonary Medicine" - 9 trials, "Northwest Georgia Oncology Centers PC" - 7 trials, "Northwest Georgia Oncology Centers, P.C." - 5 trials, "Wellstar Infectious Disease" - 3 trials, "Pinnacle Orthopaedics, Wellstone Kennestone Hospital" - 2 trials